-
ASCO: Roche, Jazz's Zepzelca small cell lung cancer win leaves room for improvement
23 May 2025 00:55 GMT
… position in small cell lung cancer with Jazz Pharmaceuticals’ Zepzelca … line extensive-stage small cell lung cancer (ES-SCLC) significantly … or in combination with irinotecan against the physician’s … choice of topotecan or irinotecan.
Jazz in-licensed U …
-
Seven lung cancer companies advancing new treatments in 2025
20 May 2025 13:28 GMT
… EGFR ex20ins inhibitor
Lead lung cancer candidate: Zipalertinib
Recent … Jazz Pharmaceuticals’ lead lung cancer drug is called Zepzelca … or in combination with irinotecan (a type of … settings outside of lung cancer.
Lung cancer treatment market expected …
-
Bristol Myers Squibb Receives European Commission Approval for Perioperative Regimen of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Adjuvant Opdivo for Resectable, High-Risk Non-Small Cell Lung Cancer with PD-L1 Expression ≥1%
16 May 2025 11:14 GMT
… and MPR.
About Lung Cancer
Lung cancer is the leading cause … a fluoropyrimidine, oxaliplatin, and irinotecan.
OPDIVO® (nivolumab), … metastatic non-small cell lung cancer, in combination with … lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
Antibody-Based Therapeutics in Small Cell Lung Cancer: A Narrative Review
15 Apr 2025 14:11 GMT
… to SN-38, an irinotecan metabolite with TOP1 inhibition … patients with small cell lung cancer. Lung Cancer. 2018;115:116–120 … patients with small cell lung cancer. Lung Cancer. 2020;147:237–243 … in metastatic small cell lung cancers and patient-derived models. …
-
Bristol Myers Squibb Receives Positive CHMP Opinion for Perioperative Regimen of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Opdivo for Resectable Non-Small Cell Lung Cancer in Patients with Tumor Cell PD-L1...
28 Mar 2025 13:11 GMT
… four tumor types: lung cancer, bladder cancer, esophageal … pathologic response.
About Lung Cancer
Lung cancer is the leading … fluoropyrimidine, oxaliplatin, and irinotecan. This indication is … lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
HUTCHMED Highlights Clinical Data to be Presented at the 2025 ASCO Annual Meeting
23 May 2025 00:00 GMT
… -positive non-small cell lung cancer (“NSCLC”) with MET amplification … LBA8505
Oral Abstract Session: Lung Cancer - Non-Small Cell … 8513
Rapid Oral Session: Lung Cancer - Non-Small Cell … Fruquintinib in Combination with Irinotecan and Capecitabine as Second …
-
Bristol Myers Squibb to Present Data at ASCO® 2025 Highlighting Differentiated Research Platform of Oncology Treatments and Innovative Research Pipeline
22 May 2025 21:28 GMT
… -Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC) … a fluoropyrimidine, oxaliplatin, and irinotecan.
OPDIVO® (nivolumab), … non-small cell lung cancer, in combination with … lung cancer; Checkmate 816-neoadjuvant non-small cell lung cancer, …
-
EMD Serono Showcases Innovation in Advanced Cancers and Rare Tumors at ASCO 2025
22 May 2025 21:54 GMT
… dose-optimization part in 60 irinotecan-refractory metastatic CRC patients (3L … cancer (GC), non-small cell lung cancer (NSCLC), and pancreatic ductal adenocarcinoma …
-
Bristol Myers Squibb Announces Opdivo® Plus Chemotherapy as the First and Only Neoadjuvant-Only Immuno-Oncology Therapy to Demonstrate Statistically Significant and Clinically Meaningful Overall Survival in Resectable Non-Small Cell Lung Cancer
19 Feb 2025 12:09 GMT
… positive) non-small cell lung cancer (NSCLC).
OPDIVO® (nivolumab … fluoropyrimidine, oxaliplatin, and irinotecan. This indication is … metastatic non-small cell lung cancer, in combination with … lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
Metabolomic Analysis, Antiproliferative, Anti-Migratory, and Anti-Invasive Potential of Amlodipine in Lung Cancer Cells
19 Feb 2025 00:32 GMT
… lung cancer (NSCLC) forms approximately 80% of all lung cancer … with amlodipine.
Discussion
Lung cancer, specifically NSCLC, continues … pathway after treating lung cancer cells A549 with … N. Simvastatin enhances irinotecan-induced apoptosis in prostate …
About
© 1995-2025